PSMA PET-Positive Local Recurrences in the Prostate Bed Region and Their Coverage Based on Clinical Target Volume Delineation Guidelines from ESTRO-ACROP, PERYTON, FROGG, GFRU, and RTOG.

Saved in:
Bibliographic Details
Title: PSMA PET-Positive Local Recurrences in the Prostate Bed Region and Their Coverage Based on Clinical Target Volume Delineation Guidelines from ESTRO-ACROP, PERYTON, FROGG, GFRU, and RTOG.
Authors: Moar EF; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany., Keilholz M; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.; Bavarian Cancer Research Center, Partner Site Munich, Munich, Germany., Sheikh GT; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany., Werner RA; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany., Trapp C; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.; Bavarian Cancer Research Center, Partner Site Munich, Munich, Germany., Casuscelli J; Bavarian Cancer Research Center, Partner Site Munich, Munich, Germany.; Department of Urology, LMU University Hospital, LMU Munich, Munich, Germany., Chaloupka M; Department of Urology, LMU University Hospital, LMU Munich, Munich, Germany., Kunz WG; Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany., Kazmierczak P; Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany., Widjaja L; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany., Brose SF; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.; Bavarian Cancer Research Center, Partner Site Munich, Munich, Germany., Eze C; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.; Bavarian Cancer Research Center, Partner Site Munich, Munich, Germany., Walter F; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.; Bavarian Cancer Research Center, Partner Site Munich, Munich, Germany., Belka C; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.; Bavarian Cancer Research Center, Partner Site Munich, Munich, Germany.; German Cancer Consortium, Partner Site Munich, Munich, Germany; and., Li M; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.; Department of Radiation Oncology, Lueneburg Hospital, Lueneburg, Germany., Rogowski P; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.; Bavarian Cancer Research Center, Partner Site Munich, Munich, Germany., Schmidt-Hegemann NS; Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany; nina-sophie.hegemann@med.uni-muenchen.de.; Bavarian Cancer Research Center, Partner Site Munich, Munich, Germany.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 Mar 02; Vol. 67 (3), pp. 404-409. Date of Electronic Publication: 2026 Mar 02.
Publication Type: Journal Article
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1535-5667
DOI:10.2967/jnumed.125.271324